Literature DB >> 16239530

Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B.

Andrey P Anisimov1, Svetlana V Dentovskaya, Galina M Titareva, Irina V Bakhteeva, Rima Z Shaikhutdinova, Sergey V Balakhonov, Buko Lindner, Nina A Kocharova, Sof'ya N Senchenkova, Otto Holst, Gerald B Pier, Yuriy A Knirel.   

Abstract

Lipopolysaccharide (LPS) structure impacts the bactericidal action of cationic peptides, such as polymyxin B (PMB), and sensitivity to killing by normal human serum (NHS). Cultivation of different subspecies strains of Yersinia pestis isolated from unrelated geographic origins at various temperatures (mammals, 37 degrees C; fleas, 25 degrees C; or winter hibernation, 6 degrees C) affects LPS composition and structure. We tested the susceptibilities of various strains of Y. pestis grown at these different temperatures to PMB and serum bactericidal killing. Both properties varied significantly in response to temperature changes. In Y. pestis subsp. pestis (the main subspecies causing human plague), high levels of resistance to PMB and NHS were detected at 25 degrees C. However, at the same temperature, Y. pestis subsp. caucasica was highly sensitive to PMB. At both of the extreme temperatures, all strains were highly susceptible to PMB. At 25 degrees C and 37 degrees C, Y. pestis subsp. caucasica strain 1146 was highly susceptible to the bactericidal activity of 80% NHS. All Y. pestis strains studied were able to grow in heat-inactivated human serum or in 80% normal mouse serum. At 6 degrees C, all strains were highly sensitive to NHS. Variations in the PMB resistance of different bacterial cultures related to both the content of cationic components (4-amino-4-deoxyarabinose in lipid A and glycine in the core) and a proper combination of terminal monosaccharides in the LPS. The NHS resistance correlated with an elevated content of N-acetylglucosamine in the LPS. Structural variation in the LPS of Y. pestis correlates with the organism's ability to resist innate immunity in both fleas and mammals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239530      PMCID: PMC1273868          DOI: 10.1128/IAI.73.11.7324-7331.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Transmission factors: Yersinia pestis genes required to infect the flea vector of plague.

Authors:  B Joseph Hinnebusch
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

2.  The core structure of the lipopolysaccharide of Yersinia pestis strain KM218. Influence of growth temperature.

Authors:  Tat'yana A Gremyakova; Evgeny V Vinogradov; Buko Lindner; Nina A Kocharova; Sof'ya N Senchenkova; Aleksander S Shashkov; Yuriy A Knirel; Otto Holst; Rima Z Shaikhutdinova; Andrei P Anisimov
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

Review 3.  [Factors of Yersinia pestis providing circulation and persistence of plague pathogen in ecosystems of natural foci. Communication 2].

Authors:  A P Anisimov
Journal:  Mol Gen Mikrobiol Virusol       Date:  2002

Review 4.  [Yersinia pestis factors, assuring circulation and maintenance of the plague pathogen in natural foci ecosystems. Report 1].

Authors:  A P Anisimov
Journal:  Mol Gen Mikrobiol Virusol       Date:  2002

5.  [Characteristics of the action and nature of a bactericidal factor in the flea intestine].

Authors:  A N Alekseev; V A Bibikova; N M Khrustselevskaia; Zh K Kantarbaeva
Journal:  Parazitologiia       Date:  1972

Review 6.  Intraspecific diversity of Yersinia pestis.

Authors:  Andrey P Anisimov; Luther E Lindler; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 7.  Insect immunity and its implication in mosquito-malaria interactions.

Authors:  George Dimopoulos
Journal:  Cell Microbiol       Date:  2003-01       Impact factor: 3.715

8.  Structural characterization of lipo-oligosaccharide (LOS) from Yersinia pestis: regulation of LOS structure by the PhoPQ system.

Authors:  Paul G Hitchen; Joann L Prior; Petra C F Oyston; Maria Panico; Brendan W Wren; Richard W Titball; Howard R Morris; Anne Dell
Journal:  Mol Microbiol       Date:  2002-06       Impact factor: 3.501

9.  Variation in lipid A structure in the pathogenic yersiniae.

Authors:  Roberto Rebeil; Robert K Ernst; Brian B Gowen; Samuel I Miller; B Joseph Hinnebusch
Journal:  Mol Microbiol       Date:  2004-06       Impact factor: 3.501

Review 10.  The history of the plague and the research on the causative agent Yersinia pestis.

Authors:  Björn P Zietz; Hartmut Dunkelberg
Journal:  Int J Hyg Environ Health       Date:  2004-02       Impact factor: 5.840

View more
  26 in total

Review 1.  Yersinia--flea interactions and the evolution of the arthropod-borne transmission route of plague.

Authors:  Iman Chouikha; B Joseph Hinnebusch
Journal:  Curr Opin Microbiol       Date:  2012-03-07       Impact factor: 7.934

2.  Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B.

Authors:  Jörg Howe; Jörg Andrä; Raquel Conde; Maite Iriarte; Patrick Garidel; Michel H J Koch; Thomas Gutsmann; Ignacio Moriyón; Klaus Brandenburg
Journal:  Biophys J       Date:  2007-01-19       Impact factor: 4.033

Review 3.  Interaction between Yersinia pestis and the host immune system.

Authors:  Bei Li; Ruifu Yang
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

4.  Characterization of the six glycosyltransferases involved in the biosynthesis of Yersinia enterocolitica serotype O:3 lipopolysaccharide outer core.

Authors:  Elise Pinta; Katarzyna Anna Duda; Anna Hanuszkiewicz; Tiina A Salminen; José Antonio Bengoechea; Heidi Hyytiäinen; Buko Lindner; Joanna Radziejewska-Lebrecht; Otto Holst; Mikael Skurnik
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

5.  Origins of Yersinia pestis sensitivity to the arylomycin antibiotics and the inhibition of type I signal peptidase.

Authors:  Danielle B Steed; Jian Liu; Elizabeth Wasbrough; Lynda Miller; Stephanie Halasohoris; Jeremy Miller; Brandon Somerville; Jeremy R Hershfield; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

6.  The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens.

Authors:  Rebecca M Thomas; Richard W Titball; Petra C F Oyston; Kate Griffin; Emma Waters; Paul G Hitchen; Stephen L Michell; I Darren Grice; Jennifer C Wilson; Joann L Prior
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

7.  Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.

Authors:  Michael L Fisher; Cynthia Castillo; Joan Mecsas
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

8.  Early evolutionary loss of the lipid A modifying enzyme PagP resulting in innate immune evasion in Yersinia pestis.

Authors:  Courtney E Chandler; Erin M Harberts; Mark R Pelletier; Iyarit Thaipisuttikul; Jace W Jones; Adeline M Hajjar; Jason W Sahl; David R Goodlett; Aaron C Pride; David A Rasko; M Stephen Trent; Russell E Bishop; Robert K Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

9.  Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein.

Authors:  Sara Schesser Bartra; Katie L Styer; Deanna M O'Bryant; Matthew L Nilles; B Joseph Hinnebusch; Alejandro Aballay; Gregory V Plano
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

10.  Comparative antimicrobial activity of granulysin against bacterial biothreat agents.

Authors:  Janice J Endsley; Alfredo G Torres; Christine M Gonzales; Valeri G Kosykh; Vladimir L Motin; Johnny W Peterson; D Mark Estes; Gary R Klimpel
Journal:  Open Microbiol J       Date:  2009-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.